BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakoh T, Nakayama M, Tanaka S, Yoshitomi R, Ura Y, Nishimoto H, Fukui A, Shikuwa Y, Tsuruya K, Kitazono T. Association of serum total bilirubin with renal outcome in Japanese patients with stages 3-5 chronic kidney disease. Metabolism 2015;64:1096-102. [PMID: 26142826 DOI: 10.1016/j.metabol.2015.06.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang TL, Lin YC, Lin YC, Huang CY, Chen HH, Wu MS. Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy. J Am Heart Assoc 2017;6:e007507. [PMID: 29275374 DOI: 10.1161/JAHA.117.007507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
2 Tsujikawa H, Tanaka S, Hara M, Kawai Y, Matsukuma Y, Torisu K, Nakano T, Tsuruya K, Kitazono T. Association of Lower Serum Bilirubin With Loss of Residual Kidney Function in Peritoneal Dialysis Patients. Ther Apher Dial 2020;24:202-7. [PMID: 31207066 DOI: 10.1111/1744-9987.12865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yuan Q, Zhang H, Xie Y, Lin W, Peng L, Wang L, Huang W, Feng S, Xiao X. Development of prognostic model for patients at CKD stage 3a and 3b in South Central China using computational intelligence. Clin Exp Nephrol 2020;24:865-75. [PMID: 32740698 DOI: 10.1007/s10157-020-01909-5] [Reference Citation Analysis]
4 Li M, Li X, Liu Y, Liu X, Song Y, Zhao J, Mohan C, Wu T, Peng A, Qin L. Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia. Clin Chim Acta 2018;486:156-61. [PMID: 30076802 DOI: 10.1016/j.cca.2018.07.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Tan J, Pei G, Xu Y, Hu T, Tan L, Zhong Z, Tarun P, Tang Y, Qin W. Serum Bilirubin Is Correlated With the Progression of IgA Vasculitis With Nephritis. Front Med (Lausanne) 2021;8:596151. [PMID: 34169080 DOI: 10.3389/fmed.2021.596151] [Reference Citation Analysis]
6 Tsai MT, Tarng DC. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients. Int J Mol Sci 2018;20:E117. [PMID: 30597982 DOI: 10.3390/ijms20010117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hoshikawa K, Naito T, Akutsu S, Saotome M, Maekawa Y, Kawakami J. Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients. Basic Clin Pharmacol Toxicol 2020;126:353-63. [DOI: 10.1111/bcpt.13355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mortada I. Hyperbilirubinemia, Hypertension, and CKD: the Links. Curr Hypertens Rep 2017;19:58. [PMID: 28597405 DOI: 10.1007/s11906-017-0756-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu Y, Li M, Song Y, Liu X, Zhao J, Deng B, Peng A, Qin L. Association of serum bilirubin with renal outcomes in Han Chinese patients with chronic kidney disease. Clin Chim Acta 2018;480:9-16. [PMID: 29408172 DOI: 10.1016/j.cca.2018.01.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang J, Li Y, Han X, Hu H, Wang F, Yu C, Li X, Yang K, Yuan J, Yao P, Miao X, Wei S, Wang Y, Chen W, Liang Y, Zhang X, Guo H, Pan A, Yang H, Wu T, He M. Association between serum bilirubin levels and decline in estimated glomerular filtration rate among patients with type 2 diabetes. J Diabetes Complications 2016;30:1255-60. [PMID: 27288202 DOI: 10.1016/j.jdiacomp.2016.05.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Brahmbhatt A, Remuzzi A, Franzoni M, Misra S. The molecular mechanisms of hemodialysis vascular access failure. Kidney Int 2016;89:303-16. [PMID: 26806833 DOI: 10.1016/j.kint.2015.12.019] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 19.4] [Reference Citation Analysis]
12 Benito S, Sánchez-ortega A, Unceta N, Andrade F, Aldámiz-echevarria L, Goicolea MA, Barrio RJ. Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS. Analyst 2018;143:4448-58. [DOI: 10.1039/c8an00864g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Chan WK, Tsai SS, Li YR, Chou WY, Chen HL, Chen ST. Association between serum bilirubin levels and progression of albuminuria in Taiwanese with type 2 diabetes mellitus. Biomed J 2021;44:201-8. [PMID: 33965355 DOI: 10.1016/j.bj.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Magaye R, Gu Y, Wang Y, Su H, Zhou Q, Mao G, Shi H, Yue X, Zou B, Xu J, Zhao J. In vitro and in vivo evaluation of the toxicities induced by metallic nickel nano and fine particles. J Mol Histol 2016;47:273-86. [PMID: 27010930 DOI: 10.1007/s10735-016-9671-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li J, Liu D, Liu Z. Serum Total Bilirubin and Progression of Chronic Kidney Disease and Mortality: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:549. [PMID: 33569386 DOI: 10.3389/fmed.2020.00549] [Reference Citation Analysis]
16 Magaye R, Gu Y, Wang Y, Su H, Zhou Q, Mao G, Shi H, Yue X, Zou B, Xu J, Zhao J. In vitro and in vivo evaluation of the toxicities induced by metallic nickel nano and fine particles. J Mol Histol 2016;47:273-86. [PMID: 27010930 DOI: 10.1007/s10735-016-9671-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
17 Moolchandani K, Priyadarssini M, Rajappa M, Parameswaran S, Revathy G. Serum bilirubin: a simple routine surrogate marker of the progression of chronic kidney disease. British Journal of Biomedical Science 2016;73:188-93. [DOI: 10.1080/09674845.2016.1182674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Wang J, Guo P, Gao Z, Zhou B, Ren L, Chen Y, Zhou Q. Elevated bilirubin levels and risk of developing chronic kidney disease: a dose-response meta-analysis and systematic review of cohort studies. Int Urol Nephrol 2018;50:275-87. [PMID: 28808864 DOI: 10.1007/s11255-017-1675-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Peng YF, Wang JL, Pan GG. The correlation of serum bilirubin levels with disease activity in patients with rheumatoid arthritis. Clin Chim Acta 2017;469:187-90. [PMID: 28410854 DOI: 10.1016/j.cca.2017.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Su WY, Chu NS, Huang JC, Wu PY, Lee WH, Liu YH, Chen SC, Su HM. Low Albumin, Low Bilirubin, and High Alfa-Fetoprotein Are Associated with a Rapid Renal Function Decline in a Large Population Follow-Up Study. J Pers Med 2021;11:781. [PMID: 34442425 DOI: 10.3390/jpm11080781] [Reference Citation Analysis]
21 Zhao X, Li L, Li X, Li J, Wang D, Zhang H. The Relationship between Serum Bilirubin and Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:5256460. [PMID: 31148945 DOI: 10.1155/2019/5256460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Majoni SW, Barzi F, Hoy W, MacIsaac RJ, Cass A, Maple-Brown L, Hughes JT. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study. BMC Nephrol 2020;21:523. [PMID: 33261565 DOI: 10.1186/s12882-020-02185-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]